Edward G Shepherd1, Tami J Kelly2, Jodi A Vinsel2, Dennis J Cunningham1, Erin Keels2, Wendi Beauseau2, Richard E McClead3. 1. Department of Pediatrics, The Ohio State University, Columbus, OH; Nationwide Children's Hospital, Columbus, OH. 2. Nationwide Children's Hospital, Columbus, OH. 3. Department of Pediatrics, The Ohio State University, Columbus, OH; Nationwide Children's Hospital, Columbus, OH. Electronic address: rick.mcclead@nationwidechildrens.org.
Abstract
OBJECTIVE: To describe a quality improvement (QI) initiative that was associated with a dramatic reduction in neonatal central-line associated bloodstream infection (CLABSI) rate in a diverse group of 8 intensive care nurseries (Neonatal Services). STUDY DESIGN: A quasi-experimental time series QI initiative using the model for improvement and evidenced-based interventions. RESULTS: The aggregate CLABSI rate for Nationwide Children's Hospital-associated Neonatal Services decreased from 6.0 CLABSI per 1000 catheter days to 1.43 CLABSI per 1000 catheter days in less than 2 years and has remained in control at 0.68 per 1000 catheter days for over 5 years. Each of 8 nurseries has had a 1 year or more CLABSI-free period, including the neonatal intensive care unit with the largest patient volume, acuity, and central line usage. Aggregate Neonatal Services has experienced 3 CLABSI-free quarters since 2007. Key success factors included: (1) engagement of senior executive leadership; (2) bedside "huddles" among clinical and epidemiology staffs conducted within 72 hours after a positive blood culture; (3) implementation of chlorhexidine antisepsis and the use of chlorhexidine-impregnated catheter site discs; and (4) and establishment of a dedicated team for percutaneously inserted central catheter insertion to serve units in which central lines are placed less frequently. CONCLUSIONS: Using the model for improvement and evidenced-based interventions, this QI project has been associated with reduction in the CLABSI rate by 89%, and over 430 CLABSIs likely have been avoided.
OBJECTIVE: To describe a quality improvement (QI) initiative that was associated with a dramatic reduction in neonatal central-line associated bloodstream infection (CLABSI) rate in a diverse group of 8 intensive care nurseries (Neonatal Services). STUDY DESIGN: A quasi-experimental time series QI initiative using the model for improvement and evidenced-based interventions. RESULTS: The aggregate CLABSI rate for Nationwide Children's Hospital-associated Neonatal Services decreased from 6.0 CLABSI per 1000 catheter days to 1.43 CLABSI per 1000 catheter days in less than 2 years and has remained in control at 0.68 per 1000 catheter days for over 5 years. Each of 8 nurseries has had a 1 year or more CLABSI-free period, including the neonatal intensive care unit with the largest patient volume, acuity, and central line usage. Aggregate Neonatal Services has experienced 3 CLABSI-free quarters since 2007. Key success factors included: (1) engagement of senior executive leadership; (2) bedside "huddles" among clinical and epidemiology staffs conducted within 72 hours after a positive blood culture; (3) implementation of chlorhexidine antisepsis and the use of chlorhexidine-impregnated catheter site discs; and (4) and establishment of a dedicated team for percutaneously inserted central catheter insertion to serve units in which central lines are placed less frequently. CONCLUSIONS: Using the model for improvement and evidenced-based interventions, this QI project has been associated with reduction in the CLABSI rate by 89%, and over 430 CLABSIs likely have been avoided.
Authors: Camilla B Pimentel; A Lynn Snow; Sarah L Carnes; Nishant R Shah; Julia R Loup; Tatiana M Vallejo-Luces; Caroline Madrigal; Christine W Hartmann Journal: J Gen Intern Med Date: 2021-02-08 Impact factor: 6.473
Authors: Michaël Levy; Nolwenn Le Sache; Mostafa Mokhtari; Guy Fagherazzi; Gaelle Cuzon; Benjamin Bueno; Virginie Fouquet; Alexandra Benachi; Sergio Eleni Dit Trolli; Pierre Tissieres Journal: Ann Intensive Care Date: 2017-03-21 Impact factor: 6.925
Authors: I E Heijting; T A J Antonius; A Tostmann; W P de Boode; M Hogeveen; J Hopman Journal: Antimicrob Resist Infect Control Date: 2021-02-05 Impact factor: 4.887
Authors: Gerdina H Dubbink-Verheij; Vincent Bekker; Iris C M Pelsma; Erik W van Zwet; Vivianne E H J Smits-Wintjens; Sylke J Steggerda; Arjan B Te Pas; Enrico Lopriore Journal: Front Pediatr Date: 2017-06-20 Impact factor: 3.418